Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ACADEMIA
ACADEMIA
- Discussions on New Guidelines for Atherosclerosis Prevention Get Underway
February 9, 2016
- Japan Oncology Society Calls for Proper Use of Opdivo
January 22, 2016
- Experts Launch Japanese Society of Geriatric Pharmacy
January 7, 2016
- Shionogi Funding Research to Develop World’s First Drug for Preventing Postoperative Metastasis of Lung Cancer
January 5, 2016
- Over 200 Medical Institutions, 14 Drug Makers Participating in Project to Analyze Cancer-Related Genetic Disorders
December 14, 2015
- Viekirax Joins Fray in Hep C Market, Can It Crack into Harvoni’s Stronghold?
November 20, 2015
- Japan Geriatrics Society to Publish Guidelines for Safe Pharmacotherapy in the Elderly Next Month
November 18, 2015
- Japan Sepsis Management Guidelines to Be Revised Next Year
October 27, 2015
- Group Calls for Appropriate Dosing of Dementia Drugs
October 9, 2015
- Asia, Oceania Obesity Associations Adopt Declaration on “Obesity Disease”
October 6, 2015
- New Guidelines for Obesity Treatment to Set Thresholds to Evaluate Drugs
October 6, 2015
- Japan Hypertension Society Announces COI Guide after Diovan Woes
October 5, 2015
- JSNP Finalizes Evidence-Based Guidelines for Treatment of Schizophrenia
September 28, 2015
- Experts, Industry Execs Say Cost Calculation Drug Pricing Method Fraught with Challenges
September 8, 2015
- ASCO Immunotherapy Roundup - 9: Researcher Says Predominance of Anti-PD-1 Antibodies Not Assured
September 1, 2015
- Japan’s National Database “World’s Largest in Scale”: Kyoto University Prof. Nakayama
August 20, 2015
- Genome Sequencing Study of Biliary Tract Cancer Suggests Effectiveness of Immune Checkpoint Therapy: National Cancer Center
August 12, 2015
- St. Marianna Univ. Hospital Introduces Tougher Rules for Adopting New Drugs with Emphasis on Cost, Efficacy, and Safety
July 28, 2015
- PD-L1 Expression Key to Decide Whether to Combine Opdivo, Yervoy: Oncologist
July 21, 2015
- Japan, US Oncologists Exchange Barbs over Opdivo Costs
July 21, 2015
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…